eli lilly phase 3 trial retatrutide 🚨 BREAKING: Shows “Bariatric-Level” Weight Loss in New Phase 3 TRIUMPH-1 data show retatrutide may deliver weight-loss outcomes approaching those seen with bariatric surgery—marking one of the most Retatrutide produces up to 30.3%

Tirzepatide was approved largely based on data from the SURPASS series of clinical trials

For the first time in years, I felt like my body wasnt fighting against me anymore. Taking better care of kids Given the growing interest in weight-loss medication and surgery for young people, much needs to happen to protect their well-being, researchers and clinicians say

Thousands of personal injury claims across the country about sudden vision loss and GLP-1s have been consolidated into a single federal court process in the Eastern District of Pennsylvania

As of November 2025, an arrangement was made between the U.S

1 Most are mild to moderate and resolve with the slow titration schedule (starting at 2.5 mg, increasing every 4 weeks)

Monthly check-ins let your provider make dose adjustments and catch emerging issues including nutrient deficiencies before they compound